Rocket Pharmaceuticals (RCKTW) News Today $0.04 0.00 (-4.20%) As of 08/29/2025 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock RCKTW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Rocket Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 28, 2025 | finance.yahoo.comBank of America Upgrades Rocket Pharma Stock (RCKT) After FDA Lifts Clinical Hold on Danon Disease TrialAugust 21, 2025 | msn.comB of A Securities Upgrades Rocket Pharmaceuticals (RCKT)August 21, 2025 | msn.comRocket Pharma rises as FDA lifts clinical hold on gene therapy trialAugust 20, 2025 | msn.comRocket Pharmaceuticals stock soars after FDA lifts clinical holdAugust 20, 2025 | investing.comRocket Pharmaceuticals upgraded to Buy from Neutral at BofAAugust 20, 2025 | msn.comRocket Pharma's shares soar after US FDA lets gene therapy trial resumeAugust 20, 2025 | msn.comRocket Pharmaceuticals surges as FDA lifts clinical hold on Phase 2 trialAugust 20, 2025 | msn.comRocket Pharmaceuticals: Reeling From Dreaded Acronyms CRL And SAEAugust 18, 2025 | seekingalpha.comRocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026August 15, 2025 | seekingalpha.comJefferies Sticks to Its Hold Rating for Rocket Pharmaceuticals (RCKT)August 12, 2025 | theglobeandmail.comNeedham Remains a Hold on Rocket Pharmaceuticals (RCKT)August 12, 2025 | theglobeandmail.comRocket Pharmaceuticals Restructures, Lays Off 30% of Workforce to Focus on Cardiovascular, LAD-I Gene TherapiesAugust 1, 2025 | msn.comRocket Pharmaceuticals Gets FDA Designation to Speed Heart-Disease Treatment DevelopmentJuly 17, 2025 | marketwatch.comRocket Pharmaceuticals Receives FDA IND Clearance for BAG3-DCM Gene Therapy RP-A701July 15, 2025 | msn.comGlorilla to headline Z107.9 Summer Jam 2025 at Rocket ArenaJuly 15, 2025 | msn.comAustralia Fires First HIMARS Long-Range Rocket in War Game With USJuly 14, 2025 | usnews.comBlackpearl tech firm moves to buy US company B2B RocketJuly 13, 2025 | msn.comFormer Laval Rocket Defenseman Noel Hoefenmayer Signs In RussiaJuly 13, 2025 | sports.yahoo.comShareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT ...July 12, 2025 | morningstar.comMCramer's Lightning Round: Rocket Lab is a buyJuly 12, 2025 | msn.comCivilian astronaut, Space Camp alum announces $15 million donation to U.S. Space & Rocket CenterJuly 12, 2025 | msn.comFormer Houston Rocket Jalen Green not surprised by being traded to Phoenix Suns. 'I had a feeling'July 12, 2025 | msn.comRCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit - MorningstarJuly 9, 2025 | morningstar.comMBrabus Rocket GTS Deep Blue Is A Carbon Fiber Clownshoe With A Thousand HorsepowerJuly 8, 2025 | msn.com2025-07-01 | Investor Alert: Deadline Approaching to Join Rocket Pharmaceuticals, Inc. (RCKT) Class Action - Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - StockhouseJuly 3, 2025 | stockhouse.com2025-07-01 | Investors in Rocket Pharmaceuticals, Inc. (RCKT): Protect Your Rights - Contact Levi & Korsinsky Before August 11, 2025 | NDAQ:RCKT | Press Release - StockhouseJuly 3, 2025 | stockhouse.comRocket Pharmaceuticals stock rises after FDA clearance for heart failure therapyJune 30, 2025 | investing.comRocket Pharmaceuticals receives FDA clearance of RP-A701June 30, 2025 | msn.comRocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart FailureJune 30, 2025 | msn.comDavis Thompson makes incredible 3 eagles in 8 holes in Round 3 of Rocket ClassicJune 28, 2025 | msn.com2025 Rocket Classic picks, odds, field: Surprising predictions from golf model that's nailed 15 majorsJune 26, 2025 | msn.comRocket Classic leaderboard for Round 1: Start time, tee times, TV channel, streamingJune 26, 2025 | msn.comLaw Offices of Frank R. Cruz Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors To Inquire About Securities Fraud Class Action - Business WireJune 24, 2025 | businesswire.comRocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman - MorningstarJune 24, 2025 | morningstar.comMSecurities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced - Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities ...June 21, 2025 | tmcnet.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJune 21, 2025 | morningstar.comMSecurities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading ...June 21, 2025 | businesswire.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJune 20, 2025 | tmcnet.comRocket Classic 2025 field: Former U.S. Open champion Matt Fitzpatrick commits to DetroitJune 10, 2025 | msn.comWhy Space Stock Rocket Lab Soared TodayJune 10, 2025 | fool.comEvercore ISI Downgrades Rocket Pharmaceuticals (RCKT) Stock, Slashes PTJune 2, 2025 | msn.comLeerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease BlowMay 29, 2025 | msn.comWilliam Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial SetbackMay 29, 2025 | msn.comRocket Pharmaceuticals: Despite FDA Clinical Hold On RP-A501, Prospects Remain IntactMay 29, 2025 | seekingalpha.comLeerink Partners Downgrades Rocket Pharmaceuticals (RCKT)May 29, 2025 | msn.comNeedham Downgrades Rocket Pharmaceuticals (RCKT)May 28, 2025 | msn.comRocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient DeathMay 27, 2025 | msn.comCoreWeave, Rocket Pharmaceuticals, SoundHound: Trending TickersMay 27, 2025 | finance.yahoo.comFDA halts Rocket Pharma's gene therapy trial as patient diesMay 27, 2025 | msn.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCKTW Media Mentions By Week RCKTW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKTW News Sentiment▼0.931.11▲Average Medical News Sentiment RCKTW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKTW Articles This Week▼22▲RCKTW Articles Average Week Get the Latest News and Ratings for RCKTW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AIMDW News BCTXW News GDTC News ENGNW News FBIOP News GLPG News GOVXW News INDV News INCR News JSPRW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKTW) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKTW Stock Alerts